4
Changes in Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0001104659-26-018136
Chief Operating Officer sold 4,302 shares at an average $79.40 ($341,564)
- Chief Operating Officer acquired 4,302 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goin Kathleen · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,154 | $7.14 | $15,380 | 2,154 | D |
| 2026-02-18 | Exercise or conversion : show line 2 in the form 10b5-1 | +2,148 | $9.08 | $19,504 | 4,302 | D |
| 2026-02-18 | Sale : show line 3 in the form 10b5-1 | −3,026 | $79.16 | $239,529 | 1,276 | D |
| 2026-02-18 | Sale : show line 4 in the form 10b5-1 | −1,276 | $79.97 | $102,035 | 0 | D |
| Open-market sales · 4,302 sh · avg $79.40 · $341,564 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-18 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −2,154 | 17,243 | D |
| 2026-02-18 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −2,148 | 17,184 | D |
Loading xslF345X05/tm266892-1_4seq1.xml…